Mediphage Bioceuticals is a genetic medicine company utilizing non-viral gene elements to generate safe, effective, and accessible therapeutic platforms. Their flagship platform, ministring DNA (msDNA), is an efficient, customizable, and redosable system with a higher safety profile than other vectors for the development of personalized genetic medicine and cell therapy. In addition to Mediphage’s core gene therapy pipeline, in response to the COVID-19 global crisis, Mediphage has developed a proprietary msDNA vaccine against COVID-19.

Mediphage Bioceuticals Logo



Event details

Date: June 8 - 12, 2020

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences


34 in total